 Jillian Cotter
Concepts (235)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Community-Acquired Infections | 7 | 2023 | 141 | 2.980 |
Why?
| | Pneumonia | 9 | 2023 | 568 | 2.570 |
Why?
| | Feces | 3 | 2023 | 374 | 1.270 |
Why?
| | Hospitals, Pediatric | 8 | 2022 | 479 | 1.010 |
Why?
| | Communicable Diseases | 3 | 2023 | 130 | 0.990 |
Why?
| | Respiratory Tract Infections | 3 | 2023 | 321 | 0.940 |
Why?
| | Gastroenteritis | 2 | 2023 | 65 | 0.920 |
Why?
| | Multiplex Polymerase Chain Reaction | 2 | 2021 | 45 | 0.890 |
Why?
| | Soft Tissue Infections | 2 | 2021 | 30 | 0.890 |
Why?
| | Asthma | 4 | 2024 | 2042 | 0.790 |
Why?
| | Anti-Bacterial Agents | 7 | 2023 | 1477 | 0.790 |
Why?
| | Antimicrobial Stewardship | 2 | 2021 | 94 | 0.790 |
Why?
| | Pneumonia, Bacterial | 1 | 2022 | 106 | 0.760 |
Why?
| | Child | 29 | 2024 | 18362 | 0.730 |
Why?
| | Dexamethasone | 2 | 2019 | 317 | 0.710 |
Why?
| | Cholangitis, Sclerosing | 2 | 2018 | 66 | 0.700 |
Why?
| | Respiratory Insufficiency | 1 | 2024 | 291 | 0.700 |
Why?
| | Diarrhea | 2 | 2023 | 173 | 0.690 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2019 | 14 | 0.680 |
Why?
| | Urinary Tract Infections | 1 | 2021 | 133 | 0.660 |
Why?
| | Prednisone | 2 | 2019 | 231 | 0.650 |
Why?
| | Clostridium Infections | 1 | 2019 | 56 | 0.650 |
Why?
| | Patient Care | 1 | 2019 | 103 | 0.630 |
Why?
| | Liver Function Tests | 2 | 2018 | 103 | 0.620 |
Why?
| | Gastrointestinal Diseases | 1 | 2020 | 183 | 0.610 |
Why?
| | Pediatricians | 1 | 2019 | 122 | 0.600 |
Why?
| | Liver Cirrhosis | 1 | 2018 | 228 | 0.530 |
Why?
| | Education, Medical, Graduate | 1 | 2019 | 374 | 0.510 |
Why?
| | Retrospective Studies | 17 | 2024 | 12543 | 0.460 |
Why?
| | Child, Hospitalized | 2 | 2023 | 38 | 0.400 |
Why?
| | Humans | 42 | 2024 | 114925 | 0.380 |
Why?
| | Prospective Studies | 8 | 2023 | 6218 | 0.380 |
Why?
| | Practice Patterns, Physicians' | 1 | 2019 | 1177 | 0.370 |
Why?
| | Hospitalization | 6 | 2022 | 1754 | 0.360 |
Why?
| | Emergency Service, Hospital | 7 | 2023 | 1813 | 0.340 |
Why?
| | Intervertebral Disc Degeneration | 2 | 2014 | 29 | 0.330 |
Why?
| | Cross-Sectional Studies | 6 | 2023 | 4406 | 0.300 |
Why?
| | Infant | 10 | 2023 | 7936 | 0.290 |
Why?
| | Patient Safety | 2 | 2019 | 278 | 0.270 |
Why?
| | Influenza, Human | 2 | 2023 | 546 | 0.270 |
Why?
| | Child, Preschool | 7 | 2021 | 9083 | 0.270 |
Why?
| | Transforming Growth Factor beta3 | 1 | 2014 | 8 | 0.230 |
Why?
| | Diskectomy | 1 | 2014 | 17 | 0.230 |
Why?
| | Thrombocythemia, Essential | 1 | 2014 | 6 | 0.230 |
Why?
| | Primary Myelofibrosis | 1 | 2014 | 9 | 0.230 |
Why?
| | Tennis | 1 | 2014 | 5 | 0.230 |
Why?
| | Polycythemia Vera | 1 | 2014 | 12 | 0.230 |
Why?
| | Ascorbic Acid Deficiency | 1 | 2024 | 6 | 0.230 |
Why?
| | Cannula | 1 | 2024 | 17 | 0.230 |
Why?
| | Scurvy | 1 | 2024 | 12 | 0.230 |
Why?
| | Cell Survival | 2 | 2014 | 1022 | 0.230 |
Why?
| | Intervertebral Disc | 1 | 2014 | 37 | 0.220 |
Why?
| | Hospitals, Community | 1 | 2024 | 45 | 0.220 |
Why?
| | Matrix Attachment Region Binding Proteins | 1 | 2013 | 4 | 0.220 |
Why?
| | Hypertension, Portal | 1 | 2014 | 61 | 0.220 |
Why?
| | Portal Vein | 1 | 2014 | 76 | 0.220 |
Why?
| | Curriculum | 2 | 2019 | 845 | 0.210 |
Why?
| | Spinal Fractures | 1 | 2014 | 76 | 0.210 |
Why?
| | Clinical Competence | 2 | 2019 | 901 | 0.210 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2023 | 61 | 0.210 |
Why?
| | Low Back Pain | 1 | 2014 | 95 | 0.200 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2024 | 129 | 0.200 |
Why?
| | Seizures, Febrile | 1 | 2022 | 19 | 0.200 |
Why?
| | Viruses | 1 | 2023 | 94 | 0.200 |
Why?
| | Respiratory Syncytial Virus Infections | 1 | 2023 | 98 | 0.200 |
Why?
| | Lumbar Vertebrae | 1 | 2014 | 211 | 0.200 |
Why?
| | Femur Neck | 1 | 2012 | 59 | 0.200 |
Why?
| | Adolescent | 6 | 2024 | 17826 | 0.190 |
Why?
| | Hospital Medicine | 1 | 2022 | 82 | 0.190 |
Why?
| | Fever | 1 | 2022 | 279 | 0.190 |
Why?
| | Intracranial Aneurysm | 2 | 2008 | 91 | 0.190 |
Why?
| | Virus Diseases | 1 | 2023 | 196 | 0.190 |
Why?
| | Aftercare | 1 | 2022 | 187 | 0.180 |
Why?
| | Mentoring | 1 | 2022 | 101 | 0.180 |
Why?
| | Pseudomonas Infections | 1 | 2022 | 185 | 0.180 |
Why?
| | Propensity Score | 1 | 2022 | 224 | 0.180 |
Why?
| | Administration, Intravenous | 1 | 2021 | 125 | 0.180 |
Why?
| | Endpoint Determination | 1 | 2020 | 69 | 0.180 |
Why?
| | Severity of Illness Index | 4 | 2022 | 2542 | 0.180 |
Why?
| | Skin Diseases, Infectious | 1 | 2020 | 15 | 0.180 |
Why?
| | Blood Culture | 1 | 2020 | 9 | 0.180 |
Why?
| | Hematopoietic Stem Cells | 1 | 2013 | 345 | 0.170 |
Why?
| | Respiration, Artificial | 1 | 2024 | 526 | 0.170 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2022 | 191 | 0.170 |
Why?
| | Male | 11 | 2023 | 55655 | 0.170 |
Why?
| | Bone and Bones | 1 | 2012 | 278 | 0.170 |
Why?
| | Mandatory Reporting | 1 | 2019 | 45 | 0.170 |
Why?
| | Pulmonologists | 1 | 2019 | 16 | 0.170 |
Why?
| | Symptom Flare Up | 1 | 2019 | 38 | 0.170 |
Why?
| | Rotator Cuff Injuries | 1 | 2019 | 53 | 0.170 |
Why?
| | Patient Readmission | 2 | 2021 | 608 | 0.160 |
Why?
| | Drug Substitution | 1 | 2019 | 46 | 0.160 |
Why?
| | Competency-Based Education | 1 | 2019 | 66 | 0.160 |
Why?
| | Time-to-Treatment | 1 | 2019 | 147 | 0.150 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 1 | 2018 | 16 | 0.150 |
Why?
| | Biliary Tract | 1 | 2018 | 16 | 0.150 |
Why?
| | Arthroscopy | 1 | 2019 | 200 | 0.150 |
Why?
| | Immunocompromised Host | 1 | 2019 | 196 | 0.150 |
Why?
| | Otitis Media | 1 | 2020 | 143 | 0.150 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 718 | 0.140 |
Why?
| | Universities | 1 | 2019 | 339 | 0.140 |
Why?
| | Polymerase Chain Reaction | 1 | 2020 | 995 | 0.140 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2008 | 1134 | 0.140 |
Why?
| | Pandemics | 2 | 2023 | 1325 | 0.140 |
Why?
| | Consensus | 1 | 2019 | 534 | 0.140 |
Why?
| | Sepsis | 1 | 2022 | 508 | 0.140 |
Why?
| | Patient Discharge | 1 | 2022 | 768 | 0.140 |
Why?
| | Hospitalists | 1 | 2019 | 174 | 0.130 |
Why?
| | Incidence | 2 | 2020 | 2316 | 0.130 |
Why?
| | Preleukemia | 1 | 2015 | 2 | 0.130 |
Why?
| | Colorado | 3 | 2020 | 4089 | 0.130 |
Why?
| | Anti-Inflammatory Agents | 1 | 2019 | 451 | 0.130 |
Why?
| | Schools | 1 | 2018 | 400 | 0.130 |
Why?
| | Female | 9 | 2021 | 59571 | 0.130 |
Why?
| | Self Report | 1 | 2019 | 696 | 0.130 |
Why?
| | Quality of Life | 2 | 2023 | 2359 | 0.120 |
Why?
| | Treatment Outcome | 4 | 2019 | 9105 | 0.120 |
Why?
| | Communication | 1 | 2019 | 747 | 0.110 |
Why?
| | Prevalence | 1 | 2020 | 2251 | 0.110 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 502 | 0.110 |
Why?
| | Lumbosacral Region | 1 | 2013 | 46 | 0.110 |
Why?
| | Cystic Fibrosis | 1 | 2022 | 956 | 0.110 |
Why?
| | Internship and Residency | 2 | 2019 | 944 | 0.110 |
Why?
| | Trans-Activators | 1 | 2015 | 368 | 0.110 |
Why?
| | Medical Errors | 1 | 2013 | 85 | 0.100 |
Why?
| | Intraoperative Complications | 1 | 2013 | 122 | 0.100 |
Why?
| | Age Factors | 1 | 2019 | 2891 | 0.100 |
Why?
| | Polymorphism, Genetic | 2 | 2013 | 612 | 0.100 |
Why?
| | Spine | 1 | 2013 | 136 | 0.100 |
Why?
| | Proto-Oncogene Proteins | 1 | 2015 | 611 | 0.100 |
Why?
| | Inflammation | 2 | 2008 | 2485 | 0.100 |
Why?
| | Surveys and Questionnaires | 2 | 2019 | 4634 | 0.090 |
Why?
| | Pediatrics | 1 | 2018 | 984 | 0.090 |
Why?
| | Liver Transplantation | 1 | 2017 | 706 | 0.090 |
Why?
| | Liver | 1 | 2018 | 1634 | 0.090 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2015 | 536 | 0.080 |
Why?
| | Postoperative Complications | 1 | 2019 | 2132 | 0.080 |
Why?
| | Primary Health Care | 1 | 2018 | 1515 | 0.080 |
Why?
| | Biomarkers | 1 | 2018 | 3418 | 0.070 |
Why?
| | Length of Stay | 2 | 2023 | 949 | 0.070 |
Why?
| | Disease Progression | 3 | 2019 | 2392 | 0.070 |
Why?
| | Inflammation Mediators | 1 | 2008 | 476 | 0.060 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2102 | 0.060 |
Why?
| | Aggrecans | 1 | 2014 | 14 | 0.060 |
Why?
| | Organ Culture Techniques | 1 | 2014 | 141 | 0.060 |
Why?
| | Fracture Healing | 1 | 2014 | 76 | 0.060 |
Why?
| | Penicillins | 1 | 2023 | 52 | 0.060 |
Why?
| | Proteoglycans | 1 | 2014 | 107 | 0.060 |
Why?
| | Ascorbic Acid | 1 | 2024 | 110 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 2 | 2024 | 3053 | 0.050 |
Why?
| | Patient Acuity | 1 | 2022 | 42 | 0.050 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2013 | 88 | 0.050 |
Why?
| | Bone Development | 1 | 2012 | 47 | 0.050 |
Why?
| | Cell Polarity | 1 | 2013 | 131 | 0.050 |
Why?
| | Tensile Strength | 1 | 2012 | 88 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2013 | 115 | 0.050 |
Why?
| | Goals | 1 | 2022 | 151 | 0.050 |
Why?
| | Cattle | 1 | 2014 | 924 | 0.050 |
Why?
| | Peer Group | 1 | 2022 | 203 | 0.050 |
Why?
| | Cell Lineage | 1 | 2013 | 310 | 0.050 |
Why?
| | Cadaver | 1 | 2012 | 303 | 0.050 |
Why?
| | Mentors | 1 | 2022 | 158 | 0.050 |
Why?
| | Benchmarking | 1 | 2022 | 161 | 0.050 |
Why?
| | ROC Curve | 1 | 2022 | 448 | 0.050 |
Why?
| | Stress, Mechanical | 1 | 2012 | 447 | 0.040 |
Why?
| | Absenteeism | 1 | 2020 | 40 | 0.040 |
Why?
| | Pseudomonas aeruginosa | 1 | 2022 | 299 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2023 | 499 | 0.040 |
Why?
| | Regression Analysis | 1 | 2012 | 947 | 0.040 |
Why?
| | Guideline Adherence | 1 | 2023 | 490 | 0.040 |
Why?
| | Biomechanical Phenomena | 1 | 2012 | 671 | 0.040 |
Why?
| | Adult | 4 | 2019 | 30604 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2013 | 529 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2014 | 827 | 0.040 |
Why?
| | Bone Density | 1 | 2012 | 430 | 0.040 |
Why?
| | Bacteremia | 1 | 2020 | 159 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2013 | 799 | 0.040 |
Why?
| | Anti-Infective Agents | 1 | 2020 | 225 | 0.040 |
Why?
| | Chronic Disease | 1 | 2023 | 1593 | 0.040 |
Why?
| | Animals | 4 | 2015 | 31837 | 0.040 |
Why?
| | Shoulder Joint | 1 | 2019 | 159 | 0.040 |
Why?
| | Clinical Protocols | 1 | 2019 | 232 | 0.040 |
Why?
| | Range of Motion, Articular | 1 | 2019 | 355 | 0.040 |
Why?
| | Acute Disease | 1 | 2020 | 915 | 0.040 |
Why?
| | Japan | 1 | 2017 | 87 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2013 | 1022 | 0.040 |
Why?
| | Biopsy, Needle | 1 | 2017 | 183 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2013 | 2586 | 0.030 |
Why?
| | Inpatients | 1 | 2020 | 380 | 0.030 |
Why?
| | Internationality | 1 | 2017 | 144 | 0.030 |
Why?
| | Teaching | 1 | 2018 | 223 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2013 | 1699 | 0.030 |
Why?
| | Recovery of Function | 1 | 2019 | 572 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2017 | 623 | 0.030 |
Why?
| | Blotting, Northern | 1 | 2005 | 193 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2013 | 3897 | 0.030 |
Why?
| | Middle Aged | 3 | 2019 | 26801 | 0.030 |
Why?
| | Fatty Acid Desaturases | 1 | 2005 | 29 | 0.030 |
Why?
| | Arabidopsis Proteins | 1 | 2005 | 65 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2014 | 3549 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2326 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2017 | 1227 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2017 | 1080 | 0.030 |
Why?
| | Survival Analysis | 1 | 2017 | 1220 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2013 | 4718 | 0.030 |
Why?
| | Mice | 2 | 2015 | 14935 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1440 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 929 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2017 | 1635 | 0.030 |
Why?
| | Aged | 2 | 2019 | 19120 | 0.030 |
Why?
| | Blotting, Western | 1 | 2005 | 1151 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 1801 | 0.030 |
Why?
| | Neurosurgical Procedures | 1 | 2013 | 154 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2013 | 539 | 0.020 |
Why?
| | Orthopedics | 1 | 2013 | 121 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2012 | 6363 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 5035 | 0.020 |
Why?
| | Risk | 1 | 2013 | 815 | 0.020 |
Why?
| | Internet | 1 | 2013 | 599 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 4427 | 0.020 |
Why?
| | Risk Assessment | 1 | 2017 | 2975 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2005 | 2558 | 0.020 |
Why?
| | Genotype | 1 | 2013 | 1775 | 0.020 |
Why?
| | Risk Factors | 2 | 2013 | 8637 | 0.020 |
Why?
| | Rupture | 1 | 2008 | 95 | 0.020 |
Why?
| | Cohort Studies | 1 | 2017 | 4903 | 0.020 |
Why?
| | United States | 1 | 2022 | 12209 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2008 | 446 | 0.020 |
Why?
| | Hemodynamics | 1 | 2008 | 1014 | 0.010 |
Why?
| | Sex Factors | 1 | 2008 | 1721 | 0.010 |
Why?
| | Proteins | 1 | 2008 | 912 | 0.010 |
Why?
| | Endothelium, Vascular | 1 | 2008 | 848 | 0.010 |
Why?
| | Smoking | 1 | 2008 | 1391 | 0.010 |
Why?
| | Hypertension | 1 | 2008 | 1059 | 0.010 |
Why?
| | Apoptosis | 1 | 2008 | 2371 | 0.010 |
Why?
|
|
Cotter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|